about
Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implicationsCurrent Research Therapeutic Strategies for Alzheimer's Disease TreatmentImaging of Leukocyte Trafficking in Alzheimer's DiseaseFunction and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegenerationTowards Personalized Intervention for Alzheimer's DiseaseAlzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice.Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.Differential Toxicity of Antibodies to the Prion Protein.Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearanceThe endocytic pathway in microglia during health, aging and Alzheimer's disease.Flow-cytometric screening of aggregation-inhibitors using a fluorescence-assisted intracellular method.Young microglia restore amyloid plaque clearance of aged microglia.Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease.In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid ImmunotherapyRecapitulating amyloid β and tau pathology in human neural cell culture models: clinical implications.Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in MiceAlzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules.The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradationSodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic SystemThree-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method.A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides.The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Protein misfolding in neurodegenerative diseases: implications and strategies.New drugs in psychiatry: focus on new pharmacological targets.Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.Strategies for dementia prevention: latest evidence and implications.Developing therapeutic vaccines against Alzheimer's disease.Central nervous system myeloid cells as drug targets: current status and translational challenges.Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.Recombinant Antibody Fragments for Neurodegenerative Diseases.Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.Genetics of Frontotemporal Dementia.
P2860
Q26740418-11DF646D-CF28-4897-A8FF-FFBB5C796415Q26765530-BDCB1AD2-582F-4B24-92B2-F4AB05CD2336Q26766489-3774D04F-C12A-461E-9EFD-70DFEE3D1057Q28080073-455DF29F-E068-4523-A4CF-61B9A9C1E7E1Q28080098-C4CC495A-967F-48A2-B9F8-8DA1288D0488Q30244736-04AD16E1-75D7-43AE-9F9E-2CBE7D88FCA2Q30835636-40BB3FC0-BAA4-4BA6-9744-81084C37EBF6Q33715454-D2FA9F2B-7744-4064-9D67-17F92A469BD4Q33731321-D6B00949-CFD8-43A1-8144-D08185D9B71FQ35907379-477AD48C-F04C-4982-817F-99A4A908A6DBQ35972878-D047C398-AC34-4F1A-8E7E-B26FB2DD0F19Q36073450-4D4FFC51-7331-4D28-8921-60E2C836B869Q36078890-4E4AB92A-1444-4E11-A7BC-16AF7FC4E8ABQ36196851-D28DEE77-48F8-47D4-A7FB-4A1D664FFE10Q36231976-27E44303-BD6D-4DA2-BFA6-574E0AF965B0Q36681437-4974DAB5-AB54-4076-B9A3-AC12A9E23763Q36715449-66C2BD68-471C-4D16-9350-E3D2561A4126Q36715710-5EA9CD4F-D6BD-46F8-B445-FB87325A8000Q37053799-31B63CA9-E628-4898-9323-55B8FB518A62Q37057272-4389F2DD-20B3-4411-A011-462B23CC39EBQ37085168-AA0479F8-C32E-479B-90F2-F2710B0476E3Q37172017-10FCE09A-58C6-4E25-B949-8B4A72AC2358Q37292581-45112F93-5984-43A3-B7E0-B0D47B3D9B77Q37604055-3B6DA9DB-0866-40FF-8A65-81F9C6C49ACEQ37615463-0109102C-5CE8-47CE-A559-87517DBD85EAQ37630548-7A7CA152-68B2-4687-A703-FFC6D13A8616Q37697832-A13505CC-788C-421F-956E-3DEBB15E6B0EQ37730207-0AA28BC3-54C5-4848-9FB2-8104AD202367Q38540633-49F76A43-2B55-4120-B106-326D695FF5EAQ38621253-64F8E3CC-8346-4C6E-81DE-5B21BA1344EFQ38636151-59464131-429A-46AB-9ECE-0545980A147FQ38658658-7ADA7B38-6AAD-4F95-A50F-F0D8B0D8D3BCQ38742951-2331FCCE-5EF6-47A7-B6F2-48A761AFCE59Q38781022-B759CF9C-B16A-4F5D-B33E-92A18F6C2605Q38802634-3BE410BD-BDBB-4B1A-85EB-B0A77034627DQ38807908-8B021DC2-86E8-4811-A88D-8D50DEECC66DQ38873518-401D1C21-8D36-4414-947D-27125974E9D1Q38970823-39A673A4-3356-4D94-A995-3C4A316547B9Q39009840-74C502CA-DDC5-4BDA-A4BD-F3323193632EQ39017699-A173EE83-EE0B-47CD-B0CD-F4B3554532F6
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immunotherapeutic approaches for Alzheimer's disease
@ast
Immunotherapeutic approaches for Alzheimer's disease
@en
Immunotherapeutic approaches for Alzheimer's disease
@nl
type
label
Immunotherapeutic approaches for Alzheimer's disease
@ast
Immunotherapeutic approaches for Alzheimer's disease
@en
Immunotherapeutic approaches for Alzheimer's disease
@nl
prefLabel
Immunotherapeutic approaches for Alzheimer's disease
@ast
Immunotherapeutic approaches for Alzheimer's disease
@en
Immunotherapeutic approaches for Alzheimer's disease
@nl
P2860
P3181
P1433
P1476
Immunotherapeutic approaches for Alzheimer's disease
@en
P2093
Fernando Goñi
P2860
P304
P3181
P356
10.1016/J.NEURON.2014.12.064
P407
P577
2015-03-18T00:00:00Z